Page last updated: 2024-10-24

candesartan and Leukocytosis

candesartan has been researched along with Leukocytosis in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Leukocytosis: A transient increase in the number of leukocytes in a body fluid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Julius, S1
Egan, BM1
Kaciroti, NA1
Nesbitt, SD1
Chen, AK1

Trials

1 trial available for candesartan and Leukocytosis

ArticleYear
In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension.
    Journal of hypertension, 2014, Volume: 32, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure;

2014